19-55401467-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014501.3(UBE2S):c.638C>T(p.Thr213Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000178 in 1,607,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014501.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2S | ENST00000264552.14 | c.638C>T | p.Thr213Met | missense_variant | Exon 4 of 4 | 1 | NM_014501.3 | ENSP00000264552.8 | ||
RPL28 | ENST00000560055.5 | c.325-1476G>A | intron_variant | Intron 4 of 4 | 3 | ENSP00000452763.1 | ||||
UBE2S | ENST00000587845.5 | c.*112C>T | downstream_gene_variant | 2 | ENSP00000467409.1 | |||||
UBE2S | ENST00000589978.1 | c.*321C>T | downstream_gene_variant | 5 | ENSP00000466388.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000125 AC: 29AN: 232516Hom.: 0 AF XY: 0.000117 AC XY: 15AN XY: 128564
GnomAD4 exome AF: 0.000186 AC: 271AN: 1455020Hom.: 0 Cov.: 29 AF XY: 0.000191 AC XY: 138AN XY: 724004
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.638C>T (p.T213M) alteration is located in exon 4 (coding exon 4) of the UBE2S gene. This alteration results from a C to T substitution at nucleotide position 638, causing the threonine (T) at amino acid position 213 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at